Week in Review: Finding Courage and Inspiration Through Personal Experiences

05.17.13 | By

Within minutes of Angelina Jolie’s New York Times opinion piece going live on her preventative steps against breast cancer, nearly every major news outlet in the world was covering the highly personal story. Ms.

Telling the Complete Story of Physician & Biopharmaceutical Collaboration

05.16.13 | By

It’s always tough reading biased coverage, especially when reporters continue to slam collaboration between physicians and biopharmaceutical companies. I was particularly taken aback by Roni Caryn Rabin’s treatment of the issue in New York Times’ Well blog this week.

Why Doctors Prescribe Medicines for Non-Approved Uses

05.16.13 | By

A recent article in Scientific American which explains “Why Doctors Prescribe Off-Label Drugs” caught my attention since non-approved use, also known as off-label use, of prescription medicines is often mentioned in the news without the context of why doctors choose to recommend it.

National Women’s Health Week: Can We “Have It All?”

05.15.13 | By

Can women really “have it all?” It is an age-old question that continues to generate significant societal interest and discussion.

Week in Review: Communicating for Positive Patient Outcomes

05.10.13 | By

Following our focus on young innovators this week, I’m reminded that ongoing research and innovation significantly improves the lives of patients and contributes to the health of our economy. The pace of innovation is staggering, and with so much information available at our fingertips, ensuring patients are utilizing reliable, accurate sources to make the best decisions for their health can be a challenge. Regular communication is essential.

I Am Research. Progress. Hope.

05.10.13 | By

Nobody better represents the exciting science of our sector than those who are rolling up their sleeves and engaging in innovative biopharmaceutical research every day. As a result, we at PhRMA and our member companies are excited to highlight the stories and lives of some of our inspiring scientists. These individuals epitomize the passion, diversity, excitement, commitment and intellectual prowess of biopharmaceutical scientists. And they set an example for future generations of promising biopharma researchers.

Hurricane Season is Coming!

05.10.13 | By

Hurricane season is coming. It starts in less than a month.  Now’s the time to get prepared.  Here’s a clip from the Barometer Bob Show on the Weather Radio Broadcast Network.  In this edition, Barometer Bob interviews RxResponse Executive Director Erin Mullen.

Medicines are a part of the solution

05.10.13 | By

IMS’ latest report, Declining Medicine Use and Costs: For Better or Worse, reasserts the value that medicines provide in improving patients’ health and saving money on future health care costs. It’s also a great example of how and why the life cycle of medicines works so well. 

Vendor Profile: The Antibody, The Scientist, and an Adorable Sheep; The Story of Abcam

05.10.13 | By

Last week I wrote about my experience at the US Chamber’s Small Business Summit, and noted that I would be profiling some smaller businesses who work with pharmaceutical manufacturing companies as vendors.

PhRMA Statement on FDA Benefit Risk Assessment Plan

WASHINGTON, D.C. (May 9, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President of Scientific and Regulatory Affairs Sascha Haverfield, Ph.D., issued the following statement today on the Food and Drug Administration’s (FDA) Draft PDUFA V Implementation Plan: Structured Approach to Benefit-Risk Assessment in Drug Regulatory Decision Making:


Subscribe to RSS - Opinion